‘Game changer’ Ozempic-like pill causes 13% weight loss — here’s when it could become available
This could really move the needle in the GLP-1 weight loss market. Semaglutide, the active ingredient in Ozempic and Wegovy, is injected into the fatty tissue just under the skin of the stomach, thigh or upper arm to treat obesity or Type 2 diabetes. Soon, there may be a promising alternative for the needle-averse, as … Read more